Menu

Low Social Status May Weaken Immune System in Monkeys

Life at the bottom of the pecking order ramps up inflammation, according to new research, an effect that appears to be reversible.

Nov 29, 2016
Ben Andrew Henry

UNIVERSITY OF EXETER, LAUREN BRENT

The link between social class and health in social mammals has been well documented. But new research in rhesus monkeys could shed light on the mechanism behind these observations. In a study of 45 female monkeys, researchers observed that changes in social status affected genes that associated with stress and inflammation. The lower a monkey’s social status, the more poorly her immune system performed. The findings are described in a paper published last week (November 25) in Science.

“There was nothing intrinsic about these females that made them low status versus high status,” study coauthor Noah Snyder-Mackler, of Duke University told The New York Times. “But how we manipulated their status had pervasive effects on their immune system.”

Snyder-Mackler and colleagues first placed monkeys into groups of five and observed the social hierarchy they established, while conducting tests on gene expression and immune system function. After one year, the experimenters rearranged the monkeys, reshuffling their social hierarchy.

Monkeys shifted to the bottom rungs of the social order were more likely to express high levels of genes associated with inflammation. Immune cells taken from these monkeys were also more likely to show an inflammatory response to bacteria. The finding suggests that social status influences the immune system, not vice versa.

The authors note that monkeys of lower social status have been previously shown to experience high stress, since they endure harassment by higher-ranking individuals. This study bolsters the link between stress and poor immune function.

Since social status can change during a monkey’s life, stress and its associated immune consequences can likely also change. “This suggests the health effects of status aren’t permanent, at least in adulthood,” study co-author Jenny Tung of Duke University said in a press release

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.